Guest guest Posted July 7, 2007 Report Share Posted July 7, 2007 The FDA requested that Genentech add a boxed warning around the risk of Xolair and anaphylactic reactions. The initial request came out in February. The FDA has issued two press releases around same, one in February and one in April, 2007. There have been any number of posts clarifying this, mostly from Pat and Fran. Your moderators are asking all members to read past posts on this subject before submitting new questions. As I have a couple of days off, I will try to go back through those and develop a FAQ to which we can direct new members. Thank you, Addy Group co-owner Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.